Table 2.
Clinical and biochemical data of the study subjects.
| Characteristics | T2DM with non-DHS (n = 30) | T2DM with DHS (n = 30) | p value |
|---|---|---|---|
| Age (years) | 57.80 ± 11.82 | 52.97 ± 11.22 | 0.11 |
| BMI (kg/m2) | 25.92 ± 3.28 | 26.70 ± 3.65 | 0.39 |
| FBG (mmol/L) | 9.48 ± 3.11 | 9.82 ± 2.68 | 0.65 |
| PBG (mmol/L) | 14.50 ± 4.12 | 15.00 ± 4.11 | 0.64 |
| HbA1c (%) | 9.16 ± 1.70 | 9.42 ± 1.59 | 0.54 |
| TC (mM) | 4.38 ± 1.28 | 5.57 ± 1.41 | ≤0.01 |
| TG (mM) | 1.58 ± 1.10 | 3.10 ± 1.79 | ≤0.01 |
| LDL-C (mM) | 2.79 ± 0.83 | 3.14 ± 1.14 | 0.18 |
| HDL-C (mM) | 1.13 ± 0.22 | 1.00 ± 0.29 | 0.06 |
| FCP (pg/mL) | 2.02 ± 0.67 | 2.62 ± 1.11 | ≤0.01 |
| FINS (pmol/ml) | 8.15 ± 5.08 | 12.24 ± 6.93 | ≤0.01 |
| HOMA-IR | 3.61 ± 3.10 | 5.44 ± 3.27 | 0.03 |
Data were presented as means ± SD, and t-test was applied. The two-tailed p value was significant at <0.05. DHS: damp-heat syndrome; BMI: body mass index; FBG: fasting blood glucose; PBG: postprandial plasma glucose; HbA1c: glycosylated hemoglobin; TC: total cholesterol; TG: triglycerides; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; FCP: fasting c-peptide; FINS: fasting insulin; HOMA-IR: insulin resistance index.